SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAMME

被引：0

作者：

Cohen, Stanley B. ^{[1
]}

van Vollenhoven, Ronald ^{[2
]}

Winthrop, Kevin ^{[3
]}

Zerbini, Cristiano ^{[4
]}

Tanaka, Yoshiya ^{[5
]}

Bessette, Louis ^{[6
]}

Zhang, Ying ^{[7
]}

Khan, Nasser ^{[7
]}

Hendrickson, Barbara ^{[7
]}

Enejosa, Jeffrey V. ^{[7
]}

Burmester, Gerd Rudiger ^{[8
]}

机构：

[1] Metroplex Clin Res Ctr, Dallas, TX USA

[2] ARC, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands

[3] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA

[4] Ctr Paulista Invest Clin, CEPIC, Sao Paulo, Brazil

[5] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Japan

[6] Laval Univ, Fac Med, Quebec City, PQ, Canada

[7] AbbVie Inc, Waukegan Rd, N Chicago, IL USA

[8] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany

来源：

RHEUMATOLOGY | 2020年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P209

引用

页码：96 / 96

页数：1

共 50 条

[21] INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Richez, C.
Lagunes-Galindo, I.
Liu, J.
Camp, H.
Song, Y.
Anyanwu, S.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 328 - 329
[22] INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, Stanley B.
van Vollenhoven, Ronald
Curtis, Jeffrey R.
Calabrese, Leonard
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Richez, Christophe
Lagunes-Galindo, Ivan
Liu, Jianzhong
Camp, Heidi S.
Song, Yanna
Anyanwu, Samuel I.
Burmester, Gerd R.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S105 - S105
[23] EFFICACY AND SAFETY OF UPADACITINIB IN TNFI INADEQUATE RESPONDERS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS
Fleischmann, Roy
Bessette, Louis
Hall, Stephen
Sparks, Jeffrey
Jain, Manish
Kakehasi, Adriana
Song, Yanna
Meerwein, Sebastian
DeMasi, Ryan
Suboticki, Jessica
Rubbert-Roth, Andrea
RHEUMATOLOGY, 2023, 62
[24] Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis
Cohen, Stanley
Van Vollenhoven, Ronald F.
Curtis, Jeffrey
Calabrese, Leonard
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Schlacher, Casey
Shaw, Tim
Liu, John
Enejosa, Jeffrey
Song, Yanna
Burmester, Gerd
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[25] SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Schlacher, C.
Shaw, T.
Liu, J.
Enejosa, J. J.
Song, Y.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 315 - 316
[26] Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
Bykerk, V. P.
Cush, J.
Winthrop, K.
Calabrese, L.
Lortholary, O.
de Longueville, M.
van Vollenhoven, R.
Mariette, X.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01) : 96 - 103
[27] Efficacy and safety of upadacitinib in TNFi-IR patients with rheumatoid arthritis from three Phase 3 clinical trials
Fleischmann, Roy
Bessette, Louis
Sparks, Jeffrey
Hall, Stephen
Jain, Manish
Kakehasi, Adriana
Song, Yanna
Meerwein, Sebastian
DeMasi, Ryan
Suboticki, Jessica
Rubbert-Roth, Andrea
SWISS MEDICAL WEEKLY, 2022, 152 : 14S - 16S
[28] EFFICACY AND SAFETY OF UPADACITINIB IN TNFI-IR PATIENTS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS
Fleischmann, R. M.
Bessette, L.
Sparks, J.
Hall, S.
Jain, M.
Kakehasi, A.
Song, Y.
Meerwein, S.
Demasi, R.
Suboticki, J.
Rubbert-Roth, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 618 - 619
[29] Efficacy and Safety of Upadacitinib in TNFi-IR Patients with Rheumatoid Arthritis from Three Phase 3 Clinical Trials
Fleischmann, Roy
Bessette, Louis
Sparks, Jeffrey
Hall, Stephen
Jain, Manish
Kakehasi, Adriana
Song, Yanna
Meerwein, Sebastian
DeMasi, Ryan
Suboticki, Jessica
Rubbert-Roth, Andrea
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 541 - 543
[30] Efficacy and Safety of Upadacitinib in Patients Across Races with Rheumatoid Arthritis: A Post Hoc Analysis of Six Phase 3 Clinical Trials
Wright, Grace
Mysler, Eduardo
Navarro-Millan, Iris
Tanaka, Yoshiya
Anyanwu, Samuel
Liu, Jianzhong
Tanjinatus, Oishi
Garrison, Andrew
Wells, Alvin
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 548 - 550

← 1 2 3 4 5 →